ReviewInsights into imaging2022
A review on advances in
Review in Insights into imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.
- Diagnostic performance of radiomics analysis for pulmonary cancer airway spread: a systematic review and meta-analysis.Diagnostic and interventional radiology (Ankara, Turkey) · 2025Pooled it
- Local aggressiveness and prognostic prediction in desmoid-type fibromatosis: insights fromAnnals of nuclear medicine · 2026Article
- Impact of Deep-Learning-Based Respiratory Motion Correction on [Biomedicines · 2026Article
- Advancements in Targeted Radiopharmaceuticals: Innovations in Diagnosis and Therapy for Enhanced Cancer Management.Chembiochem : a European journal of chemical biology · 2026Review
- Differentiating second primary lung cancer from pulmonary metastasis in patients of single solitary pulmonary lesion with extrapulmonary tumor using multiparametric analysis of FDG PET/CT.Annals of nuclear medicine · 2025Article
- Assessing cancer therapeutic efficacy in vivo using [Science advances · 2025Article
- Prediction of lymph node metastasis in lung adenocarcinoma using a PET/CT radiomics-based ensemble learning model and its pathological basis.Frontiers in oncology · 2025Article
- PET radiomics in lung cancer: advances and translational challenges.EJNMMI physics · 2024Review
- Article
- Case report: diagnosis and treatment of advanced high-grade serous ovarian carcinoma aided byAmerican journal of nuclear medicine and molecular imaging · 2024Article
- Review
- Multicentric study on the reproducibility and robustness of PET-based radiomics features with a realistic activity painting phantom.PloS one · 2024Article
- PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis onClinical & experimental metastasis · 2023Review
- Beyond Visual Interpretation: Quantitative Analysis and Artificial Intelligence in Interstitial Lung Disease Diagnosis "Expanding Horizons in Radiology".Diagnostics (Basel, Switzerland) · 2023Review
- Predictive value ofEuropean journal of nuclear medicine and molecular imaging · 2023Article
- Optimized 18F-FDG PET-CT Method to Improve Accuracy of Diagnosis of Metastatic Cancer.Diagnostics (Basel, Switzerland) · 2023Article
- Classification of solid pulmonary nodules using a machine-learning nomogram based onAnnals of translational medicine · 2022Article
- Radiomics in PET/CT and HRCT for systemic sclerosis-associated interstitial lung disease: breakthroughs and future directions.Radiologia brasileiraArticle
Corrections and comments
- Erratum issued
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
Abstract
Radiomics analysis quantifies the interpolation of multiple and invisible molecular features present in diagnostic and therapeutic images. Implementation of 18-fluorine-fluorodeoxyglucose positron emission tomography/computed tomography (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.